Magenta Therapeutics: Q1 Earnings Insights

Magenta Therapeutics MGTA reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Magenta Therapeutics missed estimated earnings by 25.81%, reporting an EPS of $-0.39 versus an estimate of $-0.31.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 7.33% increase in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Magenta Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.